Coeptis Therapeutics Inc.

COEP | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.99

$0.00 (0.00%)

Nov 2, 2026, 1:39 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Sep 30, 2026

21.5

-7.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $38.62M

1D Range

10.81 11.99

52W Range

6.80 21.41

Valuation (TTM)

PE -6.11

PB 0.29

EV/EBITDA -1.12

Valuation (NTM)

Forward PE N/A

Forward PEG -0.15

Price Target N/A

Cash Flow

FCF Yield -10.5%

SBC Adj. FCF Yield -29.2%

SBC Impact -179.3%

Margins

Gross Margin 16.8%

Operating Margin -792.9%

FCF Margin -144.6%

Growth (CAGR)

Revenue 3Y | 5Y 137.1% | 106.2%

Dil EPS 3Y | 5Y -36.4% | 100.0%

FCF 3Y | 5Y 23.0% | 22.1%

Returns

ROA -16.4%

ROE -48.2%

ROIC -16.7%

Financial Health

Net Cash

$15.49M

Current Ratio 7.66

Interest Coverage -43.64

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, an...

Sector Technology

Industry Software - Services

Employees 6

IPO Date Dec 17, 2020

Website coeptis.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.